INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 139 filers reported holding INTERSECT ENT INC in Q4 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $294,000 | -88.0% | 10,226 | -92.9% | 0.03% | -89.2% |
| Q1 2017 | $2,457,000 | -62.0% | 143,240 | -73.2% | 0.29% | -60.0% |
| Q4 2016 | $6,473,000 | +143.1% | 534,937 | +218.1% | 0.72% | +174.7% |
| Q3 2016 | $2,663,000 | +6.6% | 168,140 | -12.9% | 0.26% | +1.2% |
| Q2 2016 | $2,497,000 | +13.8% | 193,140 | +67.2% | 0.26% | +143.4% |
| Q1 2016 | $2,195,000 | +24288.9% | 115,540 | +36006.2% | 0.11% | – |
| Q2 2015 | $9,000 | – | 320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |